Study confirms efficacy of new vaccine for pneumonia in the elderly
The survey involved 84,496 participants aged over 65, recruited in more than 160 places of study. Part of the group took one dose of the vaccine and the remainder received placebo. Fifty-nine sentinel hospitals integrated the surveillance network to investigate cases of pneumococcal pneumonia.
For the study, the elderly were separated into two groups: one received the vaccine and the other a placebo. The vaccine tested is the 13-valent pneumococcal conjugate, which protects against 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F). study indicated a 45.6% reduction in the initial episodes of this type of pneumonia among those vaccinated in relation to the placebo group. "Evidence from CAPiTA is especially important for the elderly, a population more susceptible to pneumococcal pneumonia, as age-related immune system fragility makes it difficult to prevent disease," said Eurico Correia, Pfizer's Medical Director.
In Brazil, respiratory diseases represent the fifth most important cause of death. In 2012, for example, the Unified Health System (SUS) recorded the deaths of more than 40,000 elderly people due to pneumonia. A vaccine for the elderly against pneumonia is already available in Brazil, but it only protects against 10 serotypes of the disease. This new vaccine includes strain 19A, a strain that is resistant to antibiotics - which is now the only effective treatment for bacterial pneumonia.
According to a new study by the Centers for Disease Control and Prevention (CDC) in the United States, take measures such as avoiding weight gain, following a correct diet and practicing activity physics is often able to make the health picture of a person with diabetes normalize, coming to what could be called pre-diabetes.
Wild yellow fever, which has been generating suspected cases and even deaths in the southeast of the country, was considered under control by the Health Minister, Ricardo Barros, to the newspaper O Globo. It recognizes that cities are on the alert, but that mobilization by vaccination is key to preventing the spread of the disease.